• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戈谢病中的肝细胞癌:一项国际病例系列研究。

Hepatocellular carcinoma in Gaucher disease: an international case series.

机构信息

Department of Internal Medicine, division of Endocrinology & Metabolism, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.

Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

J Inherit Metab Dis. 2018 Sep;41(5):819-827. doi: 10.1007/s10545-018-0142-y. Epub 2018 Feb 8.

DOI:10.1007/s10545-018-0142-y
PMID:29423829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6133179/
Abstract

Gaucher disease (GD) is associated with an increased risk for malignancies. Next to hematological malignancies, the development of solid tumors in several organs has been described. The liver is one of the major storage sites involved in GD pathogenesis, and is also affected by liver-specific complications. In this case series, we describe 16 GD type 1 (GD1) patients from eight different referral centers around the world who developed hepatocellular carcinoma (HCC). Potential factors contributing to the increased HCC risk in GD patients are studied. Eleven patients had undergone a splenectomy in the past. Liver cirrhosis, one of the main risk factors for the development of HCC, was present in nine out of 14 patients for whom data was available. Three out of seven examined patients showed a transferrin saturation > 45%. In these three patients the presence of iron overload after histopathological examination of the liver was shown. Chronic hepatitis C infection was present in three of 14 examined cases. We summarized all findings and made a comparison to the literature. We recommend that GD patients, especially those with prior splenectomy or iron overload, be evaluated for signs of liver fibrosis and if found to be monitored for HCC development.

摘要

戈谢病(GD)与恶性肿瘤风险增加相关。除了血液系统恶性肿瘤外,还描述了几种器官的实体瘤的发展。肝脏是 GD 发病机制中涉及的主要储存部位之一,也受肝脏特异性并发症的影响。在本病例系列中,我们描述了来自世界各地八个不同转诊中心的 16 名戈谢病 1 型(GD1)患者,他们患有肝细胞癌(HCC)。研究了导致 GD 患者 HCC 风险增加的潜在因素。11 名患者过去曾接受过脾切除术。对于 14 名可获得数据的患者中的 9 名,存在导致 HCC 发展的主要危险因素之一的肝硬化。在 7 名接受检查的患者中,有 3 名转铁蛋白饱和度>45%。在这 3 名患者中,通过对肝脏进行组织病理学检查显示存在铁过载。在 14 例检查的病例中,有 3 例存在丙型肝炎慢性感染。我们总结了所有的发现,并与文献进行了比较。我们建议 GD 患者,特别是那些有脾切除术或铁过载史的患者,评估肝脏纤维化的迹象,如果发现有迹象,应监测 HCC 的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/6133179/1259748bc04d/10545_2018_142_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/6133179/1259748bc04d/10545_2018_142_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/6133179/1259748bc04d/10545_2018_142_Fig1_HTML.jpg

相似文献

1
Hepatocellular carcinoma in Gaucher disease: an international case series.戈谢病中的肝细胞癌:一项国际病例系列研究。
J Inherit Metab Dis. 2018 Sep;41(5):819-827. doi: 10.1007/s10545-018-0142-y. Epub 2018 Feb 8.
2
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease.1 型戈谢病患者应用振动控制瞬时弹性成像技术评估肝脏纤维化的流行率和预测因子。
Mol Genet Metab. 2018 Sep;125(1-2):64-72. doi: 10.1016/j.ymgme.2018.08.004. Epub 2018 Aug 11.
3
Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage.I 型戈谢病的肝纤维化:磁共振成像、瞬时弹性成像和铁储存参数。
PLoS One. 2013;8(3):e57507. doi: 10.1371/journal.pone.0057507. Epub 2013 Mar 15.
4
Hepatitis C in patients with β-thalassemia major. A single-centre experience.重型β地中海贫血患者丙型肝炎。单中心经验。
Ann Hematol. 2013 Jun;92(6):739-46. doi: 10.1007/s00277-013-1692-6. Epub 2013 Feb 15.
5
Liver resection for hepatocellular carcinoma in patients with hematological malignancies.血液恶性肿瘤患者的肝细胞癌肝切除术。
World J Surg Oncol. 2017 Nov 2;15(1):194. doi: 10.1186/s12957-017-1260-y.
6
No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up.在长期随访中,威尔逊病所致肝硬化患者发生肝细胞癌的风险未增加。
J Gastroenterol Hepatol. 2015 Mar;30(3):535-9. doi: 10.1111/jgh.12716.
7
Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, Japan.乙肝和丁型病毒感染患者发生肝硬化和肝细胞癌的风险:来自日本久留米的一项研究。
J Gastroenterol Hepatol. 1993 Sep-Oct;8(5):433-6. doi: 10.1111/j.1440-1746.1993.tb01543.x.
8
Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy.术前中性粒细胞与淋巴细胞比值对乙型肝炎相关肝硬化患者脾切除术后发生肝细胞癌的预测价值。
PLoS One. 2018 Apr 5;13(4):e0195336. doi: 10.1371/journal.pone.0195336. eCollection 2018.
9
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.肝硬化患者与非肝硬化患者肝细胞癌的危险因素分析:一项对213例来自印度的肝细胞癌患者的病例对照研究。
J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. doi: 10.1111/j.1440-1746.2007.04908.x. Epub 2007 Jun 7.
10
Risk factors for hepatocellular carcinoma in patients with cirrhosis.肝硬化患者肝细胞癌的危险因素。
Dig Dis Sci. 2004 May;49(5):850-3. doi: 10.1023/b:ddas.0000030098.75759.32.

引用本文的文献

1
Acid sphingomyelinase deficiency and Gaucher disease: Underdiagnosed and often treatable causes of hepatomegaly, splenomegaly, and low HDL cholesterol in lean individuals.酸性鞘磷脂酶缺乏症和戈谢病:瘦人肝肿大、脾肿大及高密度脂蛋白胆固醇降低的诊断不足且常可治疗的病因。
Hepatol Commun. 2025 Jan 7;9(1). doi: 10.1097/HC9.0000000000000621. eCollection 2025 Jan 1.
2
Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: A first step toward treatment criteria.成人慢性内脏酸性鞘磷脂酶缺乏症的自然病程:迈向治疗标准的第一步。
J Inherit Metab Dis. 2025 Jan;48(1):e12789. doi: 10.1002/jimd.12789. Epub 2024 Aug 23.
3

本文引用的文献

1
Transient Elastography (FibroScan) Performs Better Than Non-Invasive Markers in Assessing Liver Fibrosis and Cirrhosis in Autoimmune Hepatitis Patients.瞬时弹性成像(FibroScan)在评估自身免疫性肝炎患者的肝纤维化和肝硬化方面优于非侵入性标志物。
Med Sci Monit. 2017 Oct 26;23:5106-5112. doi: 10.12659/msm.907300.
2
Iron storage in liver, bone marrow and splenic Gaucheroma reflects residual disease in type 1 Gaucher disease patients on treatment.肝脏、骨髓和脾脏戈谢瘤中的铁储存反映了接受治疗的1型戈谢病患者的残留疾病情况。
Br J Haematol. 2017 Nov;179(4):635-647. doi: 10.1111/bjh.14915. Epub 2017 Sep 14.
3
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.
Insights in Molecular Therapies for Hepatocellular Carcinoma.
肝细胞癌分子疗法的见解
Cancers (Basel). 2024 May 10;16(10):1831. doi: 10.3390/cancers16101831.
4
Cancer Risk in Patients with Gaucher Disease Using Real-World Data.利用真实世界数据评估戈谢病患者的癌症风险
J Clin Med. 2023 Dec 15;12(24):7707. doi: 10.3390/jcm12247707.
5
The Complexities of Diagnosis with Co-Existing Gaucher Disease and Hemato-Oncology-A Case Report and Review of the Literature.戈谢病与血液肿瘤并存时的诊断复杂性——病例报告及文献综述
J Clin Med. 2023 Aug 25;12(17):5518. doi: 10.3390/jcm12175518.
6
Natural history and management of liver dysfunction in lysosomal storage disorders.溶酶体贮积症中肝功能障碍的自然史与管理
World J Hepatol. 2022 Oct 27;14(10):1844-1861. doi: 10.4254/wjh.v14.i10.1844.
7
Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer.鞘脂贮积症相关溶血鞘脂类在癌症中的潜在作用。
Cancers (Basel). 2022 Oct 5;14(19):4858. doi: 10.3390/cancers14194858.
8
Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry.2123 例戈谢氏病 1 型患者的癌症风险和丙种球蛋白异常在国际戈谢氏病组织戈谢氏病注册研究中的表现。
Am J Hematol. 2022 Oct;97(10):1337-1347. doi: 10.1002/ajh.26675. Epub 2022 Aug 24.
9
Update on Glycosphingolipids Abundance in Hepatocellular Carcinoma.肝细胞癌中糖脂丰度的最新研究进展。
Int J Mol Sci. 2022 Apr 19;23(9):4477. doi: 10.3390/ijms23094477.
10
Increased glucosylceramide production leads to decreased cell energy metabolism and lowered tumor marker expression in non-cancerous liver cells.葡萄糖神经酰胺产量的增加导致非癌细胞的细胞能量代谢降低和肿瘤标志物表达降低。
Cell Mol Life Sci. 2021 Nov;78(21-22):7025-7041. doi: 10.1007/s00018-021-03958-9. Epub 2021 Oct 9.
非酒精性脂肪性肝病相关肝细胞癌的特征。
Lancet Gastroenterol Hepatol. 2016 Oct;1(2):156-164. doi: 10.1016/S2468-1253(16)30018-8. Epub 2016 Sep 8.
4
Surveillance for hepatocellular carcinoma.肝细胞癌监测
Best Pract Res Clin Gastroenterol. 2016 Dec;30(6):1001-1010. doi: 10.1016/j.bpg.2016.10.006. Epub 2016 Oct 21.
5
Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.肝硬化肝脏与非肝硬化肝脏中的肝细胞癌:来自荷兰一个大型队列的结果。
Eur J Gastroenterol Hepatol. 2016 Mar;28(3):352-9. doi: 10.1097/MEG.0000000000000527.
6
Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial.依利格鲁司他与伊米苷酶治疗稳定的 1 型戈谢病患者的比较:一项 3 期、随机、开放标签、非劣效性试验。
Lancet. 2015 Jun 13;385(9985):2355-62. doi: 10.1016/S0140-6736(14)61841-9. Epub 2015 Mar 26.
7
Guidelines for quantifying iron overload.铁过载定量指南。
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):210-5. doi: 10.1182/asheducation-2014.1.210. Epub 2014 Nov 18.
8
Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver.非肝硬化肝脏中肝细胞癌(HCC)患者的特征及预后
BMC Gastroenterol. 2014 Jul 3;14:117. doi: 10.1186/1471-230X-14-117.
9
Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature.戈谢氏病中的恶性肿瘤和单克隆丙种球蛋白病;文献系统综述。
Br J Haematol. 2013 Jun;161(6):832-42. doi: 10.1111/bjh.12335. Epub 2013 Apr 18.
10
Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage.I 型戈谢病的肝纤维化:磁共振成像、瞬时弹性成像和铁储存参数。
PLoS One. 2013;8(3):e57507. doi: 10.1371/journal.pone.0057507. Epub 2013 Mar 15.